Welcome to our dedicated page for Linde Plc SEC filings (Ticker: LIN), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Linde plc filings document an Irish public company's industrial gases and engineering business, Nasdaq-listed ordinary shares, operating results and capital-structure activity. Results 8-Ks furnish quarterly and annual financial releases covering sales, operating profit, cash flow, capital expenditures, dividends and stock repurchases for a business serving chemicals and energy, food and beverage, electronics, healthcare, manufacturing, metals and mining.
Governance filings include definitive proxy materials, annual general meeting voting results, board elections, executive compensation and leadership changes. Other 8-K disclosures record euro note issuances under Linde's European debt issuance programme and related use of proceeds for general corporate purposes.
Linde plc director Robert L. Wood received a grant of 473 Restricted Stock Units (RSUs) tied to Linde ordinary shares on March 9, 2026. These RSUs convert to ordinary shares on a 1-for-1 basis and are scheduled to vest in full one year after the grant date, subject to his continued board service, with payout deferred until his board service ends. Following this award, Wood holds 2,861.001 RSUs and 14,463.4815 ordinary shares directly.
Linde plc director Alberto Weisser reported routine equity compensation activity involving restricted stock units and ordinary shares. He received a grant of 473 Restricted Stock Units that will vest and pay out in Linde ordinary shares on a one-for-one basis if he continues serving on the board through about March 9, 2027. He also exercised 470.156 previously granted RSUs into 470.156 ordinary shares at a conversion rate of one share per unit. Of those shares, 12.005 were withheld to cover tax obligations at a price of 484.74 per share, leaving him with 2,108.817 Linde ordinary shares held directly after these transactions. The filing shows no remaining derivative awards from this exercised grant.
Reynolds Paula Rosput reported acquisition or exercise transactions in this Form 4 filing.
Linde plc director Paula Rosput Reynolds received equity-based compensation in the form of 473 Restricted Stock Units and 19.808 deferred stock units, each convertible into ordinary shares on a 1-for-1 basis. The new RSU award vests in full one year after the March 9, 2026 grant date, contingent on continued Board service, with payout deferred until her Board service ends. Following these entries, she directly holds ordinary shares and a mix of vested and unvested deferred stock and restricted stock units.
Linde plc director Victoria Ossadnik reported compensation-related equity transactions. She received a grant of 473 Restricted Stock Units that will vest and pay out on or about March 9, 2027 in Linde plc ordinary shares on a one-for-one basis, subject to continued board service.
An earlier RSU award granted on March 7, 2025 vested in full on March 9, 2026 and paid out 470.156 ordinary shares on a one-for-one basis. Of these, 37.761 shares were withheld to satisfy tax obligations at a price of $484.74 per share. Following these transactions, she directly holds 3,767.583 ordinary shares.
Linde plc director Josef Kaeser reported routine equity compensation activity. He received a grant of 473 Restricted Stock Units that will vest and pay out in Linde ordinary shares on a one-for-one basis on or about March 9, 2027, subject to continued board service.
He also exercised 470.156 previously granted RSUs from a March 7, 2025 award, receiving the same number of ordinary shares on a 1-for-1 basis. Of these, 50.488 shares were withheld to cover tax obligations, leaving him with 3,024.642 ordinary shares held directly after the transactions.
GRANT HUGH reported acquisition or exercise transactions in this Form 4 filing.
Linde plc director Hugh Grant reported equity compensation awards and updated holdings. On March 9, 2026, he received 473 Restricted Stock Units and 79.233 Deferred Stock Units, each convertible into Linde ordinary shares on a one-for-one basis.
The new RSU award is scheduled to vest in full one year after the grant date, provided he continues serving on the Board, with potential pro-rata payout in certain cases. Payout of vested RSUs and deferred stock units has been deferred and will be settled in ordinary shares upon termination of his Board service, in line with Linde’s non-employee director plans.
Linde plc director Thomas Enders reported routine equity compensation transactions. He received a grant of 473 Restricted Stock Units on March 9, 2026, which are scheduled to vest and pay out in Ordinary Shares on a one-for-one basis on or about March 9, 2027, subject to continued Board service. On the same date, a prior RSU award granted on March 7, 2025 fully vested, and 470.156 Ordinary Shares were acquired upon payout on a one-for-one basis. Of those shares, 51.065 Ordinary Shares were withheld at $484.74 per share to cover tax obligations, rather than being sold on the market. After these transactions, Enders directly holds 11,013.894 Ordinary Shares, with no remaining RSU position from the exercised award.
Linde plc director Ann-Kristin Achleitner reported routine equity compensation activity. She received a grant of 473 restricted stock units that will vest and pay out in ordinary shares on or about March 9, 2027, subject to continued board service.
On the same date, a prior RSU award vested in full, converting 470.156 restricted stock units into an equal number of ordinary shares on a one-for-one basis. Of these, 32.121 ordinary shares were withheld at $484.74 per share to cover tax obligations, leaving her with 4,910.703 ordinary shares held directly after the transactions.
LIN reported proposed sales of common shares via a Form 144 indicating planned dispositions tied to recent equity vesting and option-related transactions. The excerpt lists 4,114 shares from restricted stock vesting on 03/07/2026 and 2,406 shares associated with options (granted 03/09/2020) on 03/10/2026.
This filing shows intended sales by an affiliated broker-dealer (Fidelity Brokerage Services LLC) for shares to be sold on or about the listed dates; cash consideration and timing are referenced in the entries.
LIN: A Form 144 filing reports an intended sale of 4,357 ordinary shares with an associated date of 03/07/2026. The filing also lists 9,455 common shares sold during the past three months on 02/17/2026.